Recent Quotes

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-11
REV		(EXPECTED)2021-08-11

Q1 2021		Est.		Actual		Surprise
EPS		-0.300		-0.330		-0.0300
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
TCON	TRACON Pharmaceuticals	3.75	-0.06	-1.57%		58.1M

TRACON Pharmaceuticals Frequently Asked Questions

How do I buy TRACON Pharmaceuticals (TCON) stock?

You can purchase shares of TRACON Pharmaceuticals (NASDAQ: TCON) through any online brokerage.

View our list of the best stock brokerages.

Who are TRACON Pharmaceuticals's (TCON) competitors?

Other companies in TRACON Pharmaceuticals’s space includes: PolarityTE (NASDAQ:PTE), Advaxis (NASDAQ:ADXS), Biocept (NASDAQ:BIOC), Celyad Oncology (NASDAQ:CYAD) and Cellectar Biosciences (NASDAQ:CLRB).

What is the target price for TRACON Pharmaceuticals (TCON) stock?

The latest price target for TRACON Pharmaceuticals (NASDAQ: TCON) was reported by Alliance Global Partners on June 4, 2021. The analyst firm set a price target for 13.00 expecting TCON to rise to within 12 months (a possible 246.67% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for TRACON Pharmaceuticals (TCON)?

The stock price for TRACON Pharmaceuticals (NASDAQ: TCON) is $3.75 last updated Fri Jul 30 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does TRACON Pharmaceuticals (TCON) pay a dividend?

There are no upcoming dividends for TRACON Pharmaceuticals.

When is TRACON Pharmaceuticals (NASDAQ:TCON) reporting earnings?

TRACON Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 11, 2021.

Is TRACON Pharmaceuticals (TCON) going to split?

There is no upcoming split for TRACON Pharmaceuticals.

What sector and industry does TRACON Pharmaceuticals (TCON) operate in?

TRACON Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.